文献速递慢性肾脏病遗传性与小管间质肾病肾血管病与高血压

进化肾脏病学

Evolutionary Nephrology.
PubMed 文献 · Kidney Int Rep · 2017-01-31

该文提出进化医学可补充传统肾脏病学,从终极原因解释慢性肾脏病的发生。生命史能量分配、环境错配与进化权衡(如APOL1突变、低出生体重)共同塑造肾脏易感性,结合分子遗传学与进化发育生物学可能带来新的防治策略。

要点

  • 进化医学关注慢性肾脏病的终极原因,补充传统近因解释。
  • 生命史能量分配与进化权衡解释肾脏随年龄的易感性变化。
  • 结合进化发育生物学与生命史理论可能催生新防治策略。

核心结论

  • 进化医学通过终极原因补充肾脏病学,可能为慢性肾脏病防治提供新策略。

研究设计与样本

  • 综述类文章,检索范围未在摘要中报告。

主要发现

  • 陆地环境进化适应导致肾小管能量消耗大且处于低氧高渗微环境。
  • 自然选择倾向将能量分配至维持肾单位完整性至生育年龄,约40岁后随衰老下降。
  • 慢性肾脏病风险因素包括胎儿生长受限或早产(生命史权衡致肾单位减少)、APOL1突变选择(对锥虫感染抵抗的权衡)和现代西方饮食错配致糖尿病高血压。
  • 出生时肾单位数量显著变异、肾单位异质性和生命史中肾损伤易感性变化是进化过程的结果。

临床怎么用

  • 临床可关注胎儿生长受限或早产史等生命史风险因素。
  • 理解APOL1突变等进化权衡有助于风险分层。
  • 结合分子遗传学、进化发育生物学和生命史理论探索新防治策略。

局限性

  • 摘要未报告综述的检索范围与纳入标准。
  • 进化医学提供互补视角,但延缓肾脏病的具体策略仍待探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Progressive kidney disease follows nephron loss, hyperfiltration, and incomplete repair, a process described as "maladaptive." In the past 20 years, a new discipline has emerged that expands research horizons: evolutionary medicine. In contrast to physiologic (homeostatic) adaptation, evolutionary adaptation is the result of reproductive success that reflects natural selection. Evolutionary explanations for physiologically maladaptive responses can emerge from mismatch of the phenotype with environment or evolutionary tradeoffs. Evolutionary adaptation to a terrestrial environment resulted in a vulnerable energy-consuming renal tubule and a hypoxic, hyperosmolar microenvironment. Natural selection favors successful energy investment strategy: energy is allocated to maintenance of nephron integrity through reproductive years, but this declines with increasing senescence after ~40 years of age. Risk factors for chronic kidney disease include restricted fetal growth or preterm birth (life history tradeoff resulting in fewer nephrons), evolutionary selection for APOL1 mutations (that provide resistance to trypanosome infection, a tradeoff), and modern life experience (Western diet mismatch leading to diabetes and hypertension). Current advances in genomics, epigenetics, and developmental biology have revealed proximate causes of kidney disease, but attempts to slow kidney disease remain elusive. Evolutionary medicine provides a complementary approach by addressing ultimate causes of kidney disease. Marked variation in nephron number at birth, nephron heterogeneity, and changing susceptibility to kidney injury throughout life history are the result of evolutionary processes. Combined application of molecular genetics, evolutionary developmental biology (evo-devo), developmental programming and life history theory may yield new strategies for prevention and treatment of chronic kidney disease.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Chevalier RL. Evolutionary Nephrology. Kidney Int Rep. 2017. PMID: 28845468. doi:10.1016/j.ekir.2017.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。